Human α-defensin 5 (HD5) is an arginine-rich small cationic peptide (29 35 amino acid residues) ranging from 3.5 to 4 kDa in size with six cysteines forming three intramolecular disulfi de bonds. HD5 has a broad spectrum of antimicrobial activity in vitro, and is active against a variety of bacteria, fungi, parasites and some viruses (Ganz, 2003) . HD5 peptide kills bacteria by binding electrostatically to the negatively charged membranes and forming pores within the bacterial cell membrane to further result in cell lysis (Zasloff, 2002) .
Unlike other characterized defensins, HD5 is stored in secretory vesicles as a propeptide and further processed to be a fully active form. HD5 is stored in the ileal mucosa at concentrations of 90 450 μg per cm 2 of mucosal surface area, and is suffi cient to generate microbicidal concentrations in the intestinal lumen (Ghosh et al., 2002 (Ghosh et al., 2002) . The mechanism of formation of these HD5 forms and its relevance in vivo is still not clear, but suggests that extracellular processing of this peptide occurs. Ghosh and coworkers (2002) also showed that a specifi c pattern of trypsin isozymes is expressed in Paneth cells and this protease effi ciently cleaves HD5 propeptide (precursor form) to form mature HD5 peptide. Both pro-HD5 and mature HD5 showed antimicrobial activity against broad spectrum bacteria in vitro (Ghosh et al., 2002; Porter et al., 1997a) .
Antimicrobial peptides with short amino acid sequences can be synthesized by solid phase chemical synthesis. Due to the high cost of peptide synthesis, recombinant approaches using microorganisms as the host to express short peptides can be an alternative choice (Piers et al., 1993) . The production of rHD5 using yeast expression systems is an approach to enhance the molecular stability of recombinant protein (Kwon and Yu, 1997; Mer et al., 1996; Zhu et al., 1998) . Pichia pastoris, the methylotrophic yeast, is an effi cient system for high yield biosynthesis of recombinant proteins (Cregg et al., 1993) . Several invertebrate and plant defensins have been successfully expressed in P. pastoris expression systems (Burrowers et al., 2005; Li et al., 2005) . The glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter has been characterized and was expressed at a high level using P. pastoris (Waterham et al., 1997) . Previously, the expression of human β-defensin 2 was also attempted in P. pastoris and B. subtilis. However, the expression levels were low (Chen et al., 2006) .
In this study, mature HD5 cDNA was cloned from a human lung cell cDNA and expressed as a soluble and active form using the strong constitutive GAP promoter of pGAPZαA vector in P. pastoris. The production of extracellular rHD5 was evaluated by western blot analysis. The antibacterial activity of rHD5 was determined against various pathogenic bacteria and lactic acid bacteria.
Materials and Methods
Materials. Lactobacilli MRS, peptone, agar, yeast extract, Luria-Bertani broth (LB), tryptic soy broth (TSB) were purchased from Difco Laboratories (USA). Bacteria were obtained from Bioresource Collection and Research Center (BCRC, Taiwan). The reagents for protein assay and western blot analysis were purchased from Bio-Rad (Richmond, CA, USA).
Cloning of HD5 cDNA from mRNA of human lung large cancer cell line (H661). Total RNA from human lung large cell carcinoma (H661) was extracted using a Trizol RNA extraction kit (Invitrogen, Carlsbad, CA, USA). The cDNA of mature peptides from amino acid residue 63 to 94 of HD5 gene was amplifi ed by reverse transcription-polymerase chain reaction (RT-PCR). Specifi c primers for the HD5 gene, Primer F: 5 -GAATTC AGC ATG GCC ACC TGC TAT TGC-3 and Primer R: 5 -GCGGCCGC TCA GCG ACA GCA GAG TCT GTA, were synthesized according to a cDNA sequence from GenBank (accession No. NM_021010). Restriction enzyme sites (EcoRI and NotI; underlined) at the end of the primers were introduced to facilitate subcloning of PCR product. Amplifi cation was performed using proofreading pfx DNA polymerase (Invitrogen). The reaction was performed under the following conditions: 30 s of denaturation at 94 C, 30 s of annealing at 55 C, and 30 s of extension at 72 C, 35 total cycles in a DNA thermal cycler (GeneAmp system 9700; ABI, Norwalk, CT, USA).
Construction of pGAPZα A/HD5 expression vector. The PCR product of HD5 cDNA was ligated into EcoRI/ NotI-cleaved pGAPZαA vector (Invitrogen) and then transfected into P. pastoris X-33 by electroporation (EquiBio Electroporator, Cold Spring Harbor, NY, USA). The colonies were selected by plating on YPDS agar plates (20 g/L tryptone; 10 g/L yeast extract; 20 g/L dextrose; 182.2 g/L sorbitol; 20 g/L agar) containing 100 μg/ml Zeocin. P. pastoris transformants, pGA-PZαA/HD5 (yeast-HD5), were confi rmed by PCR analysis.
Dot blot and western blot analysis of rHD5. Extracellular expression of rHD5 was analyzed by the dot blot and western blot method. Transformed (yeast-HD5) and control P. pastoris were grown in 5 ml of YPD broth (20 g/L peptone; 10 g/L yeast extract; 20 g/L dextrose) with/without 100 μg/ml Zeocin using a shaking incubator (200 rpm) at 30 C for 2 days. One milliliter of the resulting culture was inoculated into 50 ml of fresh YPD broth in a 250 ml fl ask and cultivated at 30 C in a shaking incubator (200 rpm) for 4 days. The cells were excluded by centrifugation at 5,000 g for 10 min. The supernatant was collected and subjected to further analysis. Fifty microliter cell supernatant was dotted onto a 0.22 μm nitrocellulose membrane, blocked with 5% skim milk in TTBS (50 mM Tris-Cl, pH 7.5; 0.15 M NaCl; 0.05% Tween-20). The membrane was incubated at room temperature for 2 h and then hybridized with 1 500 dilution of rabbit anti-HD5 polyclonal antibody (Alpha Diagnostic Intl., San Antonio, TX, USA). The membrane was washed and incubated for 1 h with 1 2,000 dilution of horseradish peroxidase conjugated goat anti-rabbit IgG antibody (Ab). After three washes with TTBS, antibody-reactive spots were visualized by the ECL detection system (Amersham, GE Healthcare Bio-sciences, Piscataway, NJ, USA). The images were detected using an imaging system (Syngene Bio Imaging Systems, Frederick, MD, USA).
For western blot analysis, the supernatant proteins were separated by 17% SDS-PAGE and transferred onto a 0.22 μm polyvinylidene fl uoride (PVDF) membrane at 4 C overnight using a Bio-Rad Transfer Blot apparatus. Nonspecifi c sites on the membrane were blocked with 5% skim milk for 1 h. The membranes were incubated at room temperature for 2 h with rabbit anti-HD5 polyclonal Ab and incubated for 1 h with HRP-conjugated goat anti-rabbit IgG Ab. After three washes, specifi c bands were visualized by an enhanced chemiluminescence detection system (Amersham, GE Healthcare Bio-sciences). The images were detected using the GeneGnome imaging system (Syngene BioImaging Systems, Frederick, MD, USA).
Antimicrobial activity of recombinant HD5. Antimicrobial activity was determined by the CFU (colonyforming unit) assay and paper disc agar diffusion method. To determine the initial number of CFU, 9 ml of yeast-HD5 supernatant, or 9 ml of supernatant of yeast (X-33), was mixed with 1 ml of the bacterial suspension and immediately diluted 100-fold with 10 mM sodium phosphate (pH 7.4) for initial counting. The mixed samples were incubated at 37 C in an incubator for various durations and then diluted 100-fold in 10 mM sodium phosphate (pH 7.4) for fi nal counting. All dilutions were plated in triplicates on LB or TSB agar plates. The plates were incubated at 37 C for 12 to 16 h, and the colonies were counted to calculate the number of CFU per ml.
For paper disc agar diffusion assay, the supernatants of cultured yeast-HD5 or X-33 were collected and lyophilized. After lyophilization, the powder was rehydrated by 1/10 of original volume of water. Six-mm paper discs were impregnated with rehydrated solution and allowed to dry at room temperature overnight.
Mueller-Hinton agar plates were spread with mid-exponential bacterial cultures, and the discs were applied on the top. Plates were incubated at 37 C for 48 h and the images were scanned.
Results

Construction of HD5 expression vector
A 96-bp PCR product containing a mature HD5 cDNA sequence (AA 63 -AA 94 ) was cloned from human lung large cell (H661) cDNA and inserted into the EcoRI and NotI site of pGAPZαA, to construct the pGAPZαA/HD5 vector. The plasmids were subsequently transformed into P. pastoris X-33 expression host. Zeocin-resistant P. pastoris transformants were selected on YPD with Zeocin (100 μg/ml) and further identifi ed by PCR using HD5 specifi c primers and confi rmed by DNA sequencing.
Expression of recombinant HD5
Pichia transformants harboring recombinant pGA-PZαA/HD5 plasmid were tested for extracellular expression in YPD broth containing Zeocin. Transformant yeast-HD5 and the yeast containing control vector were cultured for 5 days. The supernatants were collected for dot blot and western blot analysis. The result from dot blot analysis showed a positive signal from yeast-HD5 supernatant (Fig. 1A) . In addition, the result from western blot analysis indicated the highest level of rHD5 expression occurred after 5 days of cultivation (Fig. 1B) . The supernatant from 4-day cultivation was used in subsequent study. The growth curve of yeast-HD5 was compared with the control yeast. The results showed that HD5 expression affected the growth of the host cells, but it did not change the fi nal cell yield after 7-day culture (Fig. 2) .
Antimicrobial activity of the rHD5
To examine the antimicrobial activity of rHD5, the cell supernatants from yeast-HD5 and X-33 were mixed with tested bacteria in centrifuge tubes. The tubes were incubated at 37 C up to 72 h. The number of CFU was determined by counting colonies in culture plates. When the supernatant from yeast-HD5 was mixed with Salmonella typhimurium for 1 h, the number of CFU was lower than that in the control group (X-33). Moreover, after 3 h incubation, no CFU was detected in the yeast-HD5 supernatant incubation group (Fig. 3) . In the paper disc agar diffusion assay, the inhibition zone of Staphylococcus aureus (ATCC 21923) was detected after 24 h incubation and the diameter of the inhibition zone increased with the culture time (Fig. 4A C) . No inhibition zone was detected in the control group (supernatant from control yeast X-33) (Fig. 4D F) . The paper disc agar diffusion assay was also used to measure the antimicrobial activity against E. coli. The result showed that the inhibition zone was detected in the supernatant from yeast-HD5 (Fig. 4G H) . However, it appeared that the diameter of the inhibition zone was smaller than that of Staphylococcus aureus. The yeast-HD5 supernatant did not show antibacterial activity against Lactobacillus bulgaricus (BCRC14009; Fig.  5A ). In addition, the yeast-HD5 supernatant did not show any antibacterial activity against two other lactic acid producing bacteria (Bifi dobacterium bifi dum, BCRC11844; Bifi dobacterium longum, BCRC11847; Fig. 5C D) . Streptococcus thermophilus (BCRC12557) The number of CFU was determined in duplicate after 0, 1, 2, and 3 h of incubation with X-33 or yeast-HD5 supernatant. Each data point represents mean SEM from 3 independent experiments. Fig. 4 . Antibacterial activity of rHD5 against S. aureus and E. coil by paper disc diffusion assay.
Yeast-HD5 and X-33 were culture in YPD broth for 4 (A, D), 5 (B, E) and 6 days (C, F, G, H). The supernatant were collected and antibacterial activity determined against S. aureus (A F) and E. coil (G, H). is the only lactic acid bacteria among those tested that showed the growth inhibition by yeast-HD supernatant (Fig. 5B) .
Discussion
Human defensins are small cationic, cysteine-rich peptides with a wide range of antimicrobial activities. There are six α-and four β-defensins that differ in the localization of the cysteine residues and the three intramolecular disulfi de linkages (De Smet and Contreras, 2005) . The enteric human α-defensins HD5 are active against a variety of bacteria and fungi (Ghosh et al., 2002; Porter et al., 1997a, b) . These peptides play an important role in the host defense of the intestine including regulation of the enteric fl ora in relatively bacteria-free areas such as the small intestine, defense against invading enteric pathogens, and protection against microbial invasion in situations where mucosal barrier integrity is compromised, such as infl ammatory bowel disease.
Recent studies have conclusively demonstrated that HD5 is stored in Paneth cell granules as the precursor form (Ouellette, 2005) . However, no mature HD5 peptides have been isolated from Paneth cells. Ghosh and coworkers (2002) have identifi ed the predicted mature form of HD5 in ileal luminal aspirates, confi rming that this form of the peptide is generated in the crypt lumen following granule secretion. Furthermore, trypsin, coexpressed in human Paneth cells, is capable of processing the precursor form of HD5 into mature HD5 in vitro. It has been proposed that following secretion from Paneth cells, trypsin processes pro-HD5 to the mature form in vivo (Ghosh et al., 2002) . The mature form of HD5 is active against broad spectrum pathogens such as L. monocytogenes, S. typhimurium, S. aureus, E. coli, and Candida albicans (Ghosh et al., 2002; Nuding et al., 2009; Porter et al., 1997b) . HD5 is a potential antimicrobial peptide for therapeutic application.
Due to the antimicrobial activity of defensin, production of active recombinant defensin in E. coli usually is expressed as a fusion protein to inactive antibacterial activity. Cleavage, purifi cation and refolding are needed to obtain the active form of defensin (Huang et al., 2008) . Previously, an episomal Pichia expression vector using the strong GAP promoter was reported . Episomal expression vectors have several advantages over integration vectors because they do not require the integration procedure or the multicopy selection step. Moreover, the episomal expression vector can be readily transferred into other host strains such as protease-defi cient yeast. In this study, the HD5 gene was subcloned into the EcoRI-NotI sites of pGAPZαA/HD5 (episomal version of pGAPZαA containing the GAP promoter and α-factor secretion signal) in an attempt to produce an active recombinant HD5 peptide in the secretory form. Extracellular expression of HD5 in transformed Pichia X-33 broth using this vector was detected (Fig. 1A) . In addition, expression level of the recombinant HD5 peptide was correlated with the time of cell growth (Fig. 1B) . Two specifi c bands were detected by western blot analysis (Fig. 1B) . This result implies the possibility of O-glycosylation toward the peptide due to several serine and threonine residues in the peptide. The culture supernatant of Pichia X-33 from day 4 was used to purify rHD5 by fi ltering through an Amicon Ultra-15 centrifugal fi lter device (MW 10 kDa) to remove large molecules. The rHD5 was quantifi ed by SDS-PAGE analysis. Following the cultivation and purifi cation processes, the yield of the purifi ed rHD5 was approximately 1.0 mg/L of culture broth and relatively low compared to the recombinant goat lactoferrin produced in P. pastoris (Chen et al., 2007) . Due to the antimicrobial activity of HD5, it is crucial to investigate the growth performance of HD5-transformed Pichia X-33. The growth of DH5 transformed Pichia X-33 was slower than the wild type Pichia X-33 after 48 h incubation (Fig. 2) . This result demonstrated that expression of HD5 in Pichia X-33 slowed down the growth of yeast.
To evaluate the antibacterial activity of rHD5 against pathogens and probiotic bacteria through the bactericidal effect of rHD5, S. typhimurium, S. aureus, E. coli, L. bulgaricus, S. thermophilus, B. bifi dum and B. longum were selected. The results showed that S. typhimurium is most sensitive to rHD5 among the tested bacteria (Fig. 3) . In addition, rHD5 showed antibacterial activity against E. coli and S. aureus (Fig. 4) . These results were consistent with other reports (Ghosh et al., 2002; Nuding et al., 2009; Porter et al., 1997b) . While most of the studies focus on the HD5 of antimicrobial activity against pathogens, the infl uence of HD5 on the probiotics did not attract much attention. Because of the existence of probiotic bacteria in the intestine, it is important to investigate the effect of HD5 on the growth of probiotics. A lactic acid bacterium, L. bulgaricus, is more resistant to rHD5 compared to S. typhimurium (Fig. 5A ). In addition, three other lactic acid bacteria, S. thermophilus, B. bifi dum and B. longum (Fig. 5B D) are resistant to rHD5 in 72-h incubation time, although the rHD5 showed slight antibacterial activity against S. thermophilus (Fig. 5B) . These results indicated that the antimicrobial activity of HD5 is bacterial specifi c. Bacterial resistance to antimicrobial peptides is not a common phenomenon. Lactic acid bacteria normally live in the digestive tract. HD5 is stored in Paneth cell granules as the precursor form. The mature form of HD5 will be processed after secretion. To maintain normal bacterial fl ora in the intestine, the bacterium has to be resistant to the defense peptides which come from the small intestine. Under natural selection pressure, our data indicated the probiotic bacteria are more resistant than those pathogens.
However, the mechanism of resistance is still unclear.
In conclusion, expression of bioactive rHD5 in yeast showed selective antimicrobial activity.
